Navigation Links
Bacterial communication encourages chronic, resistant ear infections

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio, the online open-access journal of the American Society for Microbiology.

"In this study we show that communication between bacterial species promotes bacterial persistence and resistance to antibiotics, which are important considerations in the diagnosis, preventions and treatment of otitis media (OM)," says W. Edward Swords, an associate professor of microbiology and immunology and senior author of the study. Chelsie Armbruster, a Ph.D. student working in Swords' lab, co-authored the study.

OM is one of the most common childhood infections and is the leading reason for pediatric office visits and new antibiotic prescriptions to children. OM infections often persist for long periods of time and are often resistant to antibiotics. These chronic and recurrent cases of OM involve the persistence of the bacteria within a biofilm community, a state in which they are highly resistant to both natural clearance by the immune system and antibiotic treatment.

Epidemiological data indicate that the majority of chronic OM infections are polymicrobial in nature, meaning they are caused by more than one species of bacteria. Haemophilus influenzae and Moraxella catarrhalis are frequently found together in samples obtained from patients with chronic and recurrent OM.

"Interestingly, a recent study found M. catarrhalis to be more frequently associated with polymicrobial OM infections than from single-species OM infections. This suggests that the presence of other bacterial pathogens may impact the persistence of M. catarrhalis or the severity of disease caused by this species," says Swords.

In examining the dynamics between these two bacteria in culture and animal models, Swords and his colleagues discovered the H. influenzae secreted autoinducer-2 (AI-2), a chemical involved in an interbacterial method of communication known as quorum sensing, that promoted increased biofilm formation and antibiotic resistance in M. catarrhalis.

"We conclude that H. influenzae promotes M. catarrhalis persistence within polymicrobial infection biofilms via inter-species quorum signaling. AI-2 may therefore represent an ideal target for disruption of chronic polymicrobial infections," says Swords. "Moreover, these results strongly imply that successful vaccination against the unencapsulated H. influenzae strains that cause airway infections may also significantly impact chronic M. catarrhalis disease by removing a reservoir for the AI-2 signal that promotes M. catarrhalis persistence within biofilms."


Contact: Garth Hogan
American Society for Microbiology

Related medicine news :

1. FDA to Re-examine Anti-Bacterial Chemical in Soaps, Cleansers
2. Bacterial phylotype alterations in irritable bowel syndrome
3. Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities
4. Mayo Clinic Proceedings: Gabapentin opens window of communication
5. Online Housecalls, Improved Patient Care and Increased Communication Between Doctors and Healthcare Professionals Now Made Possible Through
6. NTUs Wee Kim Wee School of Communication to host International Communication Association Conference
7. Communication Program Didnt Improve Autism Symptoms
8. iPBX Hosted Communications Service from DSCI Now Includes Bria Softphone
9. Users Increase Sales and Marketing Communications 320 Percent
10. First Communications, Inc. Announces Audited Results for the Year Ended December 31, 2009
11. Esna Technologies Receives Unified Communications Magazine's 2009 Product of the Year Award
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: